期刊文献+

抑癌基因p53在原发性肝癌发病中的作用 被引量:4

Role of p53 mutation in carcinogenesis of primary hepatoma
下载PDF
导出
摘要 该文通过复习有关p53突变研究的所有文献,并将他们的研究结果做一总结分析,综述了抑癌基因p53突变在肝癌发病中的作用。结果发现:肝癌的发病机制非常复杂,涉及了一系列基因和细胞因子。同时表明肝癌的发病是一个多步骤的过程,在此过程中,HBV和AFB1是两个非常重要的致癌因子,他们可通过激活癌基因或使抑癌基因失活而发挥作用,其中发挥重要作用的基因为p53,p53249编码子的突变在肝癌发病中起着非常重要的作用。p53249编码子的突变可使p53功能丧失,同时也可使与p53相关的信号传导路径发生改变,并与其他因子共同作用,进而导致肝癌的发生。 To review the of role of p53 mutation in carcinogenesis in HCC. Revuewed all the papers on the research of p53 mutation and summarized the results. The carcinogenesis of hepatoma was more complicated, involved a lots of genes and factors. The process of carcinogenesis also involved mutiplesteps. In china, HBV and AFB1 were the two major factors that caused the primary hepatoma, they maybe lead to the hepatoma through the activation of oncogene and disfunction of tumor suppressor gene, such as p53, Rb, TGFbRⅡ etc. The most important genes in the carcinogenesis of hepatoma was p53, and the mutation of p53 in code 249 played a very important role in this process.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2008年第5期592-594,共3页 China Journal of Modern Medicine
基金 国家自然科学基金(No:30572101)
关键词 P53 原发性肝癌 发病机制 p53 primary hepatoma carcinogenesis
  • 相关文献

参考文献1

二级参考文献10

  • 1Mukhopadhy D, Tsikas L, Sukhatme VP, et al. Wild-typep53and v-Src exert opposing influences on human vascular endothelial growth factor gene expression [J]. Cancer Res, 1995, 5:6161-6165.
  • 2Weidner N, Folkman J. Tumoral vascularity as a prognostic factor in cancer. Patients: the evidence continues to grow[J]. J Pathol,1998, 184(2): 119-122.
  • 3Jackson MW, Bentel JM, Tilley WD. Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostis hyperplasia[J]. J Urol, 1997, 157(6): 2323-2328.
  • 4Fontanini G, Vignati S, Luchi M, et al. Neoangiogenesis and p53 protein in lung cancer: their prognostic role and othelial growth factor (VEGF) expression[J]. Br J Cancer, 1997, 75: 1295-1301.
  • 5Machein MR, Risan W, Plate KH. Antiangiogenic gene therapy in a rat gliama model using a dominant-negative vascular 2 [J].Hum Gene Ther, 1999, 10(7): 1117-1128.
  • 6Maeda K, Chung YS, Ogana Y, et al. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma [J].Cancer, 1996, 77(5): 858-863.
  • 7ZHANG XZ, JIN L, WANG XL, et al. Excessine expression of p53 protein in esopnageal carcinoma and cervical system and it's relationship with actiontherapy sensitirity [J]. Zhongguo Xiadai Yixue Zazhi, 2000, 10(6): 47-48.
  • 8Gary DG, Avid AG, John PS, et al. Thrombospondinl expression in bladder cancer: association with p53 alterations, tumor angiogenesis, and tumor progression[J]. J Natl Cancer Ins, 1997, 89(3): 219-227.
  • 9Volpert OV, Dameron KM, Bouck N. Sequential development of an angiogenic phenotype by human fibroblasts progression to tumorigenicity[J]. Oncogene, 1997, 14(12): 1495-1502.
  • 10Giatromanolaki A, Koukourakis MI, Stathopoulos GP, et al. Angiogentic in interactions of vascular endthelial growth factor othymidine phosphorylase, and of p53 protein expression in local advanced gastric cancer[J]. Oncol Res, 2000, 12(1): 33-41.

共引文献5

同被引文献46

  • 1曹晓静,戴楠,杨志祥,金丰,仲召阳,李增鹏,王阁,王东.重组人p53腺病毒治疗原发性肝癌的血清p53蛋白检测及其临床意义[J].肿瘤预防与治疗,2009,22(1):5-8. 被引量:2
  • 2李春峰,刘明.植物化学物质抗肿瘤作用的研究进展[J].实用肿瘤学杂志,2005,19(5):393-396. 被引量:3
  • 3Sheng-Cai Lin Qinxi Li.Axin bridges Daxx to p53[J].Cell Research,2007,17(4):301-302. 被引量:5
  • 4Quivrin M,Mornex F,Enachescu C,et al.Primary liver cancer[J].Cancer Radiother,2010,14(Suppl 1):S103-110.
  • 5Malaguarnera M,Di Rosa M,Nicoletti F,et al.Molecular mecha-nisms involved in NAFLD progression[J].J Mol Med,2009,87:679-695.
  • 6Saadat N,Gupta S V.Potential role of garcinol as an anticancer agent[J].J Oncology,2012,2012:647206.
  • 7Padhye S,Ahmad A,Oswal N,et al.Emerging role of Garcinol,the antioxidant chalcone from Garcinia indica Choisy and its synthetic analogs[J].J Hematology Oncology,2009,2:38.
  • 8Panda V,Ashar H,Srinath S.Antioxidant and hepatoprotective effect of Garcinia indica fruit rind in ethanol-induced hepatic damage in rodents[J].Interdisciplinary toxicology,2012,5 (4):207-213.
  • 9Cheng A C,Tsai M L,Liu C M,et al.Garcinol inhibits cell growth in hepatocellular carcinoma Hep3B cells through induction of ROS-dependent apoptosis[J].Food Function,2010,1 (3):301-307.
  • 10Koeberle A,Northoff H,Werz O.Identification of 5-lipoxygenase and microsomal prostaglandin E2 synthase-1 as functional targets of the anti-inflammatory and anti-carcinogenic garcinol[J].Biochemical Pharmacology,2009,77 (9):1513-1521.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部